Data Management and Statistical Core
Data Management and Statistical Core
批准号:
10689738
负责人:
SAYAN DASGUPTA
金额:
$33.43万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-09-18 至 2025-07-31
关键词:
AddressAgeAlgorithmsAppointmentBioinformaticsBiometryCaribbean regionChildClinical DataClinical TrialsClinical Trials UnitCollaborationsColposcopyCommunicable DiseasesDataData CollectionData Management ResourcesDiagnosisDominican RepublicDoseEnrollmentEnsureEpidemiologyGoalsHIVHIV/AIDSHealth SciencesHuman Papilloma Virus VaccinationHuman Papilloma Virus VaccineHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusImmuneImmunotherapyIndividualInformation DisseminationInfrastructureInternationalInterruptionLatin AmericaLeadershipLesionMalignant neoplasm of cervix uteriMethodsMissionMonitorOperative Surgical ProceduresPap smearPapillomavirus Transforming Protein E6PersonsPeruPhysical environmentPlayPoliticsPreventionPrevention ResearchPreventive MedicinePublic HealthPublicationsReportingResearchResource-limited settingRoleSafetyScheduleScienceScientific Advances and AccomplishmentsSecureSecurityServicesSirolimusStatistical Data InterpretationStatistical MethodsTestingTimeTriageUniversitiesVaccinationVaccinesVisualVulnerable PopulationsWashingtonWomanWorkYouthautomated visual evaluationcancer preventioncervical cancer preventionclinical centerclinical databaseco-clinical trialcollaborative environmentdata managementdesignelectronic dataflexibilityimmunogenicityimprovedinnovationmembernew technologypoint of carepremalignantprimary endpointprofessorprogramsresponsescreeningsecondary endpointstandard of carestatistical centertooltreatment strategytrial design
中文摘要
项目摘要--数据管理和统计核心(DMSc)
数据管理和统计核心(DMSc)将提供有效的统计规划和数据
管理支持促进宫颈癌科研目标的顺利实现
秘鲁和多米尼加共和国的预防伙伴关系(C2P2)中心。DMSc将支持
拟议的临床试验计划将跨越接种疫苗预防宫颈癌的连续过程
通过治疗。临床试验将使用一种新的预防和治疗方法组合,旨在
护理点和低基础设施支持,以应对艾滋病毒感染患者HPV相关癌症的负担
处于低资源环境中的人。这些试验的最终目的是将该领域推向
在感染艾滋病毒的弱势人群中消除宫颈癌。试验1将确定新的给药计划
目的提高HIV感染者(CLWH)儿童接种HPV疫苗的免疫原性。审判2将
确定新技术对完善妇女艾滋病筛查和分类算法的贡献
艾滋病毒(WLWH)。试验3将评估中断癌前病变的非手术免疫治疗
WLWH进展为宫颈癌。在目标1中,DMSc将提供设计和分析支持
三项临床试验;在目标2中,DMSc将提供安全的数据管理和安全监测服务;
在目标3中,DMSC将通过应用创新的统计学来推进科学的使命
分析和方法。DMSc负责人陈博士将与伙伴关系中心的
行政管理中的科学领导,协调核心和临床试验联合主席以开发
将影响拉丁美洲/加勒比地区宫颈癌预防的高效和高质量试验
区域。
英文摘要
PROJECT SUMMARY - DATA MANAGEMENT AND STATISTICAL CORE (DMSC)
The Data Management and Statistical Core (DMSC) will provide effective statistical planning and data
management support to optimize the successful accomplishment of the scientific aims of the Cervical Cancer
Prevention Partnership (C2P2) Center in Peru and the Dominican Republic. The DMSC will support the
proposed Clinical Trials Program that will span the continuum of cervical cancer prevention from vaccination
through treatment. The clinical trials will use a new combination of prevention and treatment methods aimed at
point-of-care and low-infrastructure support to address the burden of HPV-related cancers in HIV-infected
persons in low-resource settings. The ultimate intent of these trials is to advance the field toward the
elimination of cervical cancer among vulnerable populations with HIV. Trial 1 will identify new dosing schedules
to improve the immunogenicity of HPV vaccination among children living with HIV (CLWH). Trial 2 will
ascertain the contribution of new technologies to refine algorithms for screening and triage of women living with
HIV (WLWH). Trial 3 will assess non-surgical immune-based treatments of precancerous lesions to interrupt
progression to cervical cancer in WLWH. In Aim 1, the DMSC will provide design and analysis support for the
three clinical trials; in Aim 2 the DMSC will provide secure data management and safety monitoring services;
and in Aim 3 the DMSC will advance the mission of the science through the application of innovative statistical
analysis and methods. The DMSC leader Dr. Chen will collaborate closely with the Partnership Center’s
scientific leadership in the Administrative and Coordinating Core and Clinical Trial Co-Chairs to develop
efficient and high-quality trials that will impact the prevention of cervical cancer in the Latin America/Caribbean
region.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
-
批准号:10653955
-
项目类别:
-
资助金额:$333.18万
-
财政年份:2021
-
负责人:SAYAN DASGUPTA
-
依托单位:
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
-
批准号:10475716
-
项目类别:
-
资助金额:$335.45万
-
财政年份:2021
-
负责人:SAYAN DASGUPTA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: